DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER
» See Plans and Pricing
All Clinical Trials for Brevibloc Double Strength In Plastic Container
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01114971 | Labetalol and Esmolol: Vital Signs and Post Operative Pain Management | Recruiting | Cedars-Sinai Medical Center | Phase 4 | 2009-09-01 | This study proposes to investigate the effects of labetalol or esmolol on managing the vital signs (like blood pressure and heart rate) during surgery, on pain management, and on the later recovery after surgery. It will also assess the cost-effectiveness of Labetalol and esmolol for outpatient surgery. |
| NCT01179113 | Esmolol Infusion During Laminectomy: Effect on Quality of Recovery | Terminated | Cedars-Sinai Medical Center | Phase 4 | 2011-06-01 | The purpose of this study is to evaluate the effects of esmolol, a drug which is commonly administered during surgery to help control blood pressure and heart rate, on postoperative pain levels and requirements for pain medication. |
| NCT01208402 | Esmolol for Treatment of Perioperative Tachycardia | Terminated | Baxter Healthcare Corporation | Phase 3 | 2010-09-01 | The purpose of this study is to find out if Esmolol is a safe and effective alternative treatment compared to standard treatment using a long acting beta blocker drug, in controlling abnormal heart rate before, during and immediately after surgery. |
| NCT01208402 | Esmolol for Treatment of Perioperative Tachycardia | Terminated | Duke University | Phase 3 | 2010-09-01 | The purpose of this study is to find out if Esmolol is a safe and effective alternative treatment compared to standard treatment using a long acting beta blocker drug, in controlling abnormal heart rate before, during and immediately after surgery. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Brevibloc Double Strength In Plastic Container
Condition Name
| Condition Name for Brevibloc Double Strength In Plastic Container | |
| Intervention | Trials |
| Septic Shock | 3 |
| Injection Site Irritation | 1 |
| Overdose of Beta-adrenergic Blocking Drug | 1 |
| Deviation Septum Nasal | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Export unavailable in trial.
Subscribe for complete access.
Condition MeSH
Clinical Trial Locations for Brevibloc Double Strength In Plastic Container
Trials by Country
Clinical Trial Progress for Brevibloc Double Strength In Plastic Container
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Brevibloc Double Strength In Plastic Container
Sponsor Name
